1) You may have mis-typed the URL. Try checking your spelling and then click refresh.
2) It’s possible the content you’re looking for has moved. Try using the search form at the top of the page.
1) You may have mis-typed the URL. Try checking your spelling and then click refresh.
2) It’s possible the content you’re looking for has moved. Try using the search form at the top of the page.
Novoeight® (antihemophilic factor, recombinant) is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis to reduce the frequency of bleeding episodes.